Phase 1 Evaluation of 11C-CS1P1 to Assess Safety and Dosimetry in Human Participants.

Saved in:
Bibliographic Details
Title: Phase 1 Evaluation of 11C-CS1P1 to Assess Safety and Dosimetry in Human Participants.
Authors: Brier MR; Department of Neurology, Washington University, St. Louis, Missouri., Hamdi M; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Rajamanikam J; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Zhao H; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Mansor S; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Jones LA; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Rahmani F; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Jindal S; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Koudelis D; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Perlmutter JS; Department of Neurology, Washington University, St. Louis, Missouri.; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.; Department of Neuroscience, Washington University, St. Louis, Missouri.; Department of Physical and Occupational Therapy, Washington University, St. Louis, Missouri; and., Wong DF; Department of Neurology, Washington University, St. Louis, Missouri.; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri.; Department of Neuroscience, Washington University, St. Louis, Missouri.; Department of Psychiatry, Washington University, St. Louis, Missouri., Nickels M; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Ippolito JE; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Gropler RJ; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Schindler TH; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Laforest R; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri., Tu Z; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri; benzingert@wustl.edu zhudetu@wustl.edu., Benzinger TLS; Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri; benzingert@wustl.edu zhudetu@wustl.edu.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2022 Nov; Vol. 63 (11), pp. 1775-1782. Date of Electronic Publication: 2022 Mar 24.
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1535-5667
DOI:10.2967/jnumed.121.263189